← Back to Search

Platelet Rich Fibrin

Surgical stent for Gingival Recession

Phase 1
Waitlist Available
Research Sponsored by Abdo Y Ismail
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects can withstand alginate impression or wear a retainer.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights

Study Summary

This trial will compare the healing of a donor palatal site using L-PRF, H-PRF, or a palatal stent.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are able to tolerate having an alginate impression taken or wearing a retainer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Palatal Muscles

Trial Design

3Treatment groups
Experimental Treatment
Group I: GROUP 3Experimental Treatment1 Intervention
A surgical stent will be delivered to cover the surgical site and apply pressure on the wound site.
Group II: GROUP 2Experimental Treatment1 Intervention
H-PRF membranes will be placed on the palatal donor site to help stabilizing the blood clot and release of growth factors that help in deceasing the discomfort wound healing.
Group III: GROUP 1Experimental Treatment1 Intervention
L-PRF membranes will be placed on the palatal donor site to help stabilizing the blood clot and release of growth factors that help in deceasing the discomfort wound healing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Surgical stent
2021
Completed Phase 1
~30
L-PRF (Leucocyte- platelet rich fibrin)
2021
Completed Phase 1
~30
H-PRF (Horizontal -platelet rich fibrin)
2021
Completed Phase 1
~30

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Abdo Y IsmailLead Sponsor
Mohanad Al-Sabbagh, DDS, MSStudy ChairUniversity of Kentucky
1 Previous Clinical Trials
43 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study accept individuals over 25 years old as participants?

"This study is only open to individuals between the ages of 18 and 65. For those younger than 18 or older than 65, there are 12 other trials that may be suitable for them."

Answered by AI

What is the aggregate figure of people participating in this trial?

"Affirmative. The information hosted on clinicaltrials.gov has established that this medical investigation, which was first advertised in February 2021, is actively seeking participants. Approximately 30 people are needed from a single site for enrollment."

Answered by AI

Are there presently any opportunities to join this clinical experiment?

"As per the clinicaltrials.gov records, this medical trial is actively on the lookout for eligible participants. The experiment was initially posted in February of 2021 and experienced its last update just recently in March 2022."

Answered by AI

Has the FDA given its stamp of approval to this particular Surgical stent?

"As this is a Phase 1 trial, where there are limited data supporting safety and efficacy, our Power team assigned it a score of 1 on the risk scale."

Answered by AI

Do I fulfill the requirements to participate in this clinical research?

"This scientific experiment seeks 30 human test subjects aged 18-65 who suffer from a particular medical condition. Furthermore, successful candidates must have optimal oral hygiene (as indicated by plaque and bleeding indexes of less than 20%), be able to withstand alginate impressions or retainer wear, and not require any additional surgical procedures or painkillers at the same site."

Answered by AI
~7 spots leftby Apr 2025